MedTrace Logo

Continuous Positive Airway Pressure for the Treatment of Stroke

NCT00368628 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2009-03-03

No results posted yet for this study

Summary

New stroke therapies are needed. This study seeks to provide the preliminary data needed to plan a future study that will evaluate the efficacy of using continuous positive airway pressure (CPAP) to treat stroke patients who have sleep apnea. Our goal is to use this therapy to reduce stroke symptom severity.

Conditions

Interventions

PROCEDURE

continuous positive airway pressure

Continuous Positive Airway Pressure initiated within 48 hours of stroke onset and continued for 90 days.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Dawn M Bravata, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00368628 on ClinicalTrials.gov